VALENTINI, GABRIELE
VALENTINI, GABRIELE
[Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs].
2009 Bombardieri S;Ferraccioli G;Ferri C;Galeazzi M;Lapadula G;Cerinic MM;Montecucco C;Triolo G;Trotta F;Valentini G
Anti-inflammatory: new trends in the treatment of the patient with systemic sclerosis.
2008 Valentini G;Cerinic MM
Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis.
2011 Dieudé P;Guedj M;Truchetet ME;Wipff J;Revillod L;Riemekasten G;Matucci Cerinic M;Melchers I;Hachulla E;Airo P;Diot E;Hunzelmann N;Mouthon L;Cabane J;Cracowski JL;Riccieri V;Distler J;Amoura Z;Valentini G;Camaraschi P;Tarner I;Frances C;Carpentier P;Brembilla NC;Meyer O;Kahan A;Chizzolini C;Boileau C;Allanore Y
Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research
2023 Hoffmann-Vold, Anna-Maria; Brunborg, Cathrine; Airò, Paolo; Ananyeva, Lidia P; Czirják, László; Guiducci, Serena; Hachulla, Eric; Li, Mengtao; Mihai, Carina; Riemekasten, Gabriela; Sfikakis, Petros P; Valentini, Gabriele; Kowal-Bielecka, Otylia; Allanore, Yannick; Distler, Oliver
Colchicine treatment of Behçet's disease in children.
1987 Tafi L;Matucci Cerinic M;Falcini F;Valentini G;Bartolozzi G
Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.
2002 Giacomelli R;Valentini G;Salsano F;Cipriani P;Sambo P;Conforti ML;Fulminis A;De Luca A;Farina G;Candela M;Generini S;De Francisci A;Tirri E;Proietti M;Bombardieri S;Gabrielli A;Tonietti G;Cerinic MM
Disease-specific quality indicators, guidelines and outcome measures in scleroderma.
2007 Valentini G;Matucci Cerinic M
Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis
2018 Beyer, Christian; Huscher, Dörte; Ramming, Andreas; Bergmann, Christina; Avouac, Jerome; Guiducci, Serena; Meier, Florian; Vettori, Serena; Siegert, Elise; Jaeger, Veronika K; Maurer, Britta; Riemekasten, Gabriela; Walker, Ulrich; Müller-Ladner, Ulf; Valentini, Gabriele; Matucci-Cerinic, Marco; Allanore, Yannick; Distler, Oliver; Schett, Georg; Distler, Jörg H W
Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects.
2007 Iannone F;Trotta F;Montecucco C;Giacomelli R;Galeazzi M;Matucci Cerinic M;Ferri C;Cutolo M;Maria Bambara L;Triolo G;Ferraccioli G;Valentini G;Lapadula G;GISEA (Gruppo Italiano per lo Studio delle Early Arthritis)
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
2009 Kowal-Bielecka O, Landewé R, Avouac J, Chwiesko S, Miniati I, Czirjak L, Clements P, Denton C, Farge D, Fligelstone K, Földvari I, Furst DE, Müller-Ladner U, Seibold J, Silver RM, Takehara K, Toth BG, Tyndall A, Valentini G, van den Hoogen F, Wigley F, Zulian F, Matucci-Cerinic M; EUSTAR Co-Authors.
European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research.
2009 Avouac J;Kowal-Bielecka O;Landewe R;Chwiesko S;Miniati I;Czirjak L;Clements P;Denton C;Farge D;Fligelstone K;Földvari I;Furst DE;Müller-Ladner U;Seibold J;Silver RM;Takehara K;Toth BG;Tyndall A;Valentini G;van den Hoogen F;Wigley F;Zulian F;Matucci Cerinic M;EUSTAR Coauthors
European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres.
2001 Della Rossa A;Valentini G;Bombardieri S;Bencivelli W;Silman AJ;D'Angelo S;Cerinic MM;Belch JF;Black CM;Becvar R;Bruhlman P;Cozzi F;Czirják L;Drosos AA;Dziankowska B;Ferri C;Gabrielli A;Giacomelli R;Hayem G;Inanc M;McHugh NJ;Nielsen H;Scorza R;Tirri E;van den Hoogen FH;Vlachoyiannopoulos PG
Functional disability and its predictors in systemic sclerosis: A study from the DeSScipher project within the EUSTAR group
2018 Jaeger V.K.; Distler O.; Maurer B.; Czirjak L.; Lorand V.; Valentini G.; Vettori S.; Del Galdo F.; Abignano G.; Denton C.; Nihtyanova S.; Allanore Y.; Avouac J.; Riemekasten G.; Siegert E.; Huscher D.; Matucci-Cerinic M.; Guiducci S.; Frerix M.; Tarner I.H.; Toth B.G.; Fankhauser B.; Umbricht J.; Zakharova A.; Mihai C.; Cozzi F.; Yavuz S.; Hunzelmann N.; Rednic S.; Vacca A.; Schmeiser T.; Riccieri V.; De la Pena Lefebvre P.G.; Gabrielli A.; Krummel-Lorenz B.; Martinovic D.; Ancuta C.; Smith V.; Muller-Ladner U.; Walker U.A.
Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot study.
2001 Sambo P;Amico D;Giacomelli R;Matucci Cerinic M;Salsano F;Valentini G;Gabrielli A
Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise.
2012 Fransen J;Johnson SR;van den Hoogen F;Baron M;Allanore Y;Carreira PE;Czirják L;Denton CP;Distler O;Furst DE;Gabrielli A;Herrick A;Inanc M;Kahaleh B;Kowal-Bielecka O;Medsger TA Jr;Mueller-Ladner U;Riemekasten G;Sierakowski S;Valentini G;Veale D;Vonk MC;Walker U;Chung L;Clements PJ;Collier DH;Csuka ME;Jimenez S;Merkel PA;Seibold JR;Silver R;Steen V;Tyndall A;Matucci Cerinic M;Pope JE;Khanna D
Prevalence of anti-toxoplasma antibodies in patients with autoimmune diseases.
2012 Shapira Y;Agmon-Levin N;Selmi C;Petríková J;Barzilai O;Ram M;Bizzaro N;Valentini G;Matucci Cerinic M;Anaya JM;Katz BS;Shoenfeld Y
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study
2020 Jaeger, Veronika K; Tikly, Mohammed; Xu, Dong; Siegert, Elise; Hachulla, Eric; Airò, Paolo; Valentini, Gabriele; Matucci Cerinic, Marco; Distler, Oliver; Cozzi, Franco; Carreira, Patricia; Allanore, Yannick; Müller-Ladner, Ulf; Ananieva, Lidia P; Balbir-Gurman, Alexandra; Distler, Jörg H W; Czirják, Laszlo; Li, Mengtao; Henes, Jörg; Jimenez, Sergio A; Smith, Vanessa; Damjanov, Nemanja; Denton, Christopher P; DelGaldo, Francesco; Saketkoo, Lesley Ann; Walker, Ulrich A
Rheumatology and dermatology: sister specialities in Italy and Malta.
1996 Matucci Cerinic M;Lotti T;Valentini G;Pace J;Mallia C
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis
2017 Ruscitti, Piero*; Margiotta, Domenico Paolo Emanuele; MacAluso, Federica; Iacono, Daniela; D'Onofrio, Francesca; Emmi, Giacomo; Atzeni, Fabiola; Prete, Marcella; Perosa, Federico; Sarzi-Puttini, Piercarlo; Emmi, Lorenzo; Cantatore, Francesco Paolo; Triolo, Giovanni; Afeltra, Antonella; Giacomelli, Roberto; Valentini, Gabriele
The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy.
2009 Matucci-Cerinic M; Allanore Y; Czirják L; Tyndall A; Müller-Ladner U; Denton C; Valentini G; Distler O; Fligelstone K; Tyrrel-Kennedy A; Farge D; Kowal-Bielecka O; van den Hoogen F; Cutolo M; Sampaio-Barros PD; Nash P; Takehara K; Furst DE.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| [Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs]. | 2009 | Bombardieri S;Ferraccioli G;Ferri C;Galeazzi M;Lapadula G;Cerinic MM;Montecucco C;Triolo G;Trotta F;Valentini G | |
| Anti-inflammatory: new trends in the treatment of the patient with systemic sclerosis. | 2008 | Valentini G;Cerinic MM | |
| Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis. | 2011 | Dieudé P;Guedj M;Truchetet ME;Wipff J;Revillod L;Riemekasten G;Matucci Cerinic M;Melchers I;Hachulla E;Airo P;Diot E;Hunzelmann N;Mouthon L;Cabane J;Cracowski JL;Riccieri V;Distler J;Amoura Z;Valentini G;Camaraschi P;Tarner I;Frances C;Carpentier P;Brembilla NC;Meyer O;Kahan A;Chizzolini C;Boileau C;Allanore Y | |
| Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research | 2023 | Hoffmann-Vold, Anna-Maria; Brunborg, Cathrine; Airò, Paolo; Ananyeva, Lidia P; Czirják, László; Guiducci, Serena; Hachulla, Eric; Li, Mengtao; Mihai, Carina; Riemekasten, Gabriela; Sfikakis, Petros P; Valentini, Gabriele; Kowal-Bielecka, Otylia; Allanore, Yannick; Distler, Oliver | |
| Colchicine treatment of Behçet's disease in children. | 1987 | Tafi L;Matucci Cerinic M;Falcini F;Valentini G;Bartolozzi G | |
| Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis. | 2002 | Giacomelli R;Valentini G;Salsano F;Cipriani P;Sambo P;Conforti ML;Fulminis A;De Luca A;Farina G;Candela M;Generini S;De Francisci A;Tirri E;Proietti M;Bombardieri S;Gabrielli A;Tonietti G;Cerinic MM | |
| Disease-specific quality indicators, guidelines and outcome measures in scleroderma. | 2007 | Valentini G;Matucci Cerinic M | |
| Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis | 2018 | Beyer, Christian; Huscher, Dörte; Ramming, Andreas; Bergmann, Christina; Avouac, Jerome; Guiducci, Serena; Meier, Florian; Vettori, Serena; Siegert, Elise; Jaeger, Veronika K; Maurer, Britta; Riemekasten, Gabriela; Walker, Ulrich; Müller-Ladner, Ulf; Valentini, Gabriele; Matucci-Cerinic, Marco; Allanore, Yannick; Distler, Oliver; Schett, Georg; Distler, Jörg H W | |
| Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects. | 2007 | Iannone F;Trotta F;Montecucco C;Giacomelli R;Galeazzi M;Matucci Cerinic M;Ferri C;Cutolo M;Maria Bambara L;Triolo G;Ferraccioli G;Valentini G;Lapadula G;GISEA (Gruppo Italiano per lo Studio delle Early Arthritis) | |
| EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). | 2009 | Kowal-Bielecka O, Landewé R, Avouac J, Chwiesko S, Miniati I, Czirjak L, Clements P, Denton C, Farge D, Fligelstone K, Földvari I, Furst DE, Müller-Ladner U, Seibold J, Silver RM, Takehara K, Toth BG, Tyndall A, Valentini G, van den Hoogen F, Wigley F, Zulian F, Matucci-Cerinic M; EUSTAR Co-Authors. | |
| European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research. | 2009 | Avouac J;Kowal-Bielecka O;Landewe R;Chwiesko S;Miniati I;Czirjak L;Clements P;Denton C;Farge D;Fligelstone K;Földvari I;Furst DE;Müller-Ladner U;Seibold J;Silver RM;Takehara K;Toth BG;Tyndall A;Valentini G;van den Hoogen F;Wigley F;Zulian F;Matucci Cerinic M;EUSTAR Coauthors | |
| European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. | 2001 | Della Rossa A;Valentini G;Bombardieri S;Bencivelli W;Silman AJ;D'Angelo S;Cerinic MM;Belch JF;Black CM;Becvar R;Bruhlman P;Cozzi F;Czirják L;Drosos AA;Dziankowska B;Ferri C;Gabrielli A;Giacomelli R;Hayem G;Inanc M;McHugh NJ;Nielsen H;Scorza R;Tirri E;van den Hoogen FH;Vlachoyiannopoulos PG | |
| Functional disability and its predictors in systemic sclerosis: A study from the DeSScipher project within the EUSTAR group | 2018 | Jaeger V.K.; Distler O.; Maurer B.; Czirjak L.; Lorand V.; Valentini G.; Vettori S.; Del Galdo F.; Abignano G.; Denton C.; Nihtyanova S.; Allanore Y.; Avouac J.; Riemekasten G.; Siegert E.; Huscher D.; Matucci-Cerinic M.; Guiducci S.; Frerix M.; Tarner I.H.; Toth B.G.; Fankhauser B.; Umbricht J.; Zakharova A.; Mihai C.; Cozzi F.; Yavuz S.; Hunzelmann N.; Rednic S.; Vacca A.; Schmeiser T.; Riccieri V.; De la Pena Lefebvre P.G.; Gabrielli A.; Krummel-Lorenz B.; Martinovic D.; Ancuta C.; Smith V.; Muller-Ladner U.; Walker U.A. | |
| Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot study. | 2001 | Sambo P;Amico D;Giacomelli R;Matucci Cerinic M;Salsano F;Valentini G;Gabrielli A | |
| Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise. | 2012 | Fransen J;Johnson SR;van den Hoogen F;Baron M;Allanore Y;Carreira PE;Czirják L;Denton CP;Distler O;Furst DE;Gabrielli A;Herrick A;Inanc M;Kahaleh B;Kowal-Bielecka O;Medsger TA Jr;Mueller-Ladner U;Riemekasten G;Sierakowski S;Valentini G;Veale D;Vonk MC;Walker U;Chung L;Clements PJ;Collier DH;Csuka ME;Jimenez S;Merkel PA;Seibold JR;Silver R;Steen V;Tyndall A;Matucci Cerinic M;Pope JE;Khanna D | |
| Prevalence of anti-toxoplasma antibodies in patients with autoimmune diseases. | 2012 | Shapira Y;Agmon-Levin N;Selmi C;Petríková J;Barzilai O;Ram M;Bizzaro N;Valentini G;Matucci Cerinic M;Anaya JM;Katz BS;Shoenfeld Y | |
| Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study | 2020 | Jaeger, Veronika K; Tikly, Mohammed; Xu, Dong; Siegert, Elise; Hachulla, Eric; Airò, Paolo; Valentini, Gabriele; Matucci Cerinic, Marco; Distler, Oliver; Cozzi, Franco; Carreira, Patricia; Allanore, Yannick; Müller-Ladner, Ulf; Ananieva, Lidia P; Balbir-Gurman, Alexandra; Distler, Jörg H W; Czirják, Laszlo; Li, Mengtao; Henes, Jörg; Jimenez, Sergio A; Smith, Vanessa; Damjanov, Nemanja; Denton, Christopher P; DelGaldo, Francesco; Saketkoo, Lesley Ann; Walker, Ulrich A | |
| Rheumatology and dermatology: sister specialities in Italy and Malta. | 1996 | Matucci Cerinic M;Lotti T;Valentini G;Pace J;Mallia C | |
| Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis | 2017 | Ruscitti, Piero*; Margiotta, Domenico Paolo Emanuele; MacAluso, Federica; Iacono, Daniela; D'Onofrio, Francesca; Emmi, Giacomo; Atzeni, Fabiola; Prete, Marcella; Perosa, Federico; Sarzi-Puttini, Piercarlo; Emmi, Lorenzo; Cantatore, Francesco Paolo; Triolo, Giovanni; Afeltra, Antonella; Giacomelli, Roberto; Valentini, Gabriele | |
| The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. | 2009 | Matucci-Cerinic M; Allanore Y; Czirják L; Tyndall A; Müller-Ladner U; Denton C; Valentini G; Distler O; Fligelstone K; Tyrrel-Kennedy A; Farge D; Kowal-Bielecka O; van den Hoogen F; Cutolo M; Sampaio-Barros PD; Nash P; Takehara K; Furst DE. |